Posterior uveitis is an ocular complication that can occur with reactivation of varicella-zoster virus (VZV). It may lead to loss of vision due to retinal detachment and chronic inflammation, which often causes more severe disease than the virus infection itself. To increase our understanding of the immune response, we infected the retinal pigment epithelial (RPE) cell line, ARPE-19, with cell-associated VZV and compared its response to that of the MeWo cell line using multiplex assays. We observed (1) a difference in the magnitude and kinetics of cytokine responses between the 2 cell types and (2) differential migration of CD4 + and CD8 + T cells towards these cytokines. Thus, our data provide information about the cytokine and lymphocytic responses to VZV infection of RPE cells, thereby providing a useful platform for future studies to address mechanisms underlying the immunopathology of VZVassociated posterior uveitis.
Reactivation of latent varicella-zoster virus (VZV) in the dermatomal distribution of the ophthalmic branch of the trigeminal nerve can result in herpes zoster ophthalmicus, leading to ocular complications such as uveitis. Uveitis is defined by severe inflammation of many tissues within the eye, including the iris, ciliary body, retina, and choroid, and it is associated with inflammatory cells in these tissues as well as in the aqueous and vitreous humors [1, 2] . Uveitis is a major cause of preventable blindness worldwide, especially in the working-age population [3, 4] . Acute retinal necrosis (ARN) is a rare but devastating form of posterior uveitis involving retinal detachment, chronic inflammation, and possibly loss of vision. Herpesviruses are a common infectious cause of uveitis, with VZV being responsible for the vast majority of ARN cases [5] [6] [7] . The standard treatment for herpesviral uveitis includes antivirals and corticosteroids, because control of virus replication alone is insufficient, highlighting the contributory role the immune response plays in disease progression.
However, little is known about the immunopathology of VZV-associated uveitis. Previous investigations established that T lymphocytes predominate in ocular fluids during uveitis [8, 9] . CD4 + T cells are present in the retina and choroid in active lesions [10] , and they are stimulated by a broad spectrum of VZV antigens [11] . Although reports describing the cytokine profile from ocular fluid of patients with VZV-induced uveitis have been informative [12] [13] [14] [15] [16] [17] [18] [19] , there are several limitations to these studies. First, because both infected ocular cells and leukocytes produce cytokines found in ocular fluid, their unique contribution cannot be defined. Second, it is not possible to determine the timing and sequence of cytokine expression from ocular fluid, because frequent aspiration is not feasible. Finally, obtaining a sufficient volume of ocular fluid for definitive studies of cell-mediated immunity is problematic. These challenges to studying ocular fluid from patients have hindered a better understanding of VZV-induced uveitis.
Retinal pigment epithelial (RPE) cells are a layer of resident antigen-presenting cells that plays a fundamental role in maintaining immune privilege within the eye via several mechanisms [20, 21] . First, RPE cells provide a physical barrier to incoming insults. Second, RPE cells express cell-bound and soluble-immunosuppressive factors such as Fas ligand and transforming growth factor-β, respectively. Finally, RPE cells suppress systemic immune responses to antigen that is introduced into the eye via anterior chamber-associated immune deviation [22, 23] . Viral particles and antigens have been detected in RPE of patients with VZV-induced posterior uveitis [5, 24] , demonstrating that VZV is capable of infecting RPE. Because of challenges in obtaining RPE on a regular basis and the inherent genetic differences between patient samples, we chose to use the human cell line, ARPE-19, to understand more about the immunologic responses to VZV infection of retinal cells. ARPE-19 cells, established from a primary RPE culture, possess structural and functional properties characteristic of RPE in vivo [25] . In this study, we evaluated VZV infection of ARPE-19 cells to increase our understanding of the immunopathology associated with VZV-induced uveitis.
MATERIALS AND METHODS

Cell Culture and Virus Stocks
ARPE-19, MRC-5, and MeWo cells (ATCC, Manassas, VA) were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% heat-inactivated fetal bovine serum (Gemini Bio-Products, West Sacramento, CA) at 37°C and 5% CO 2 . These cells were authenticated by STR/ID testing (Barbara Davis Center, University of Colorado Denver). Peripheral blood mononuclear cells (PBMCs) from consented healthy donors were isolated using Histopaque-1077 (Sigma-Aldrich, St. Louis, MO).
Recombinant Oka strain VZV ([ROka]; a gift from Jeff Cohen, National Institutes of Health) [26] was propagated in MRC-5 cells to generate cell-associated virus by trypsinization. Titers were typically between 10 5 and 10 6 plaque-forming units (PFU)/mL. Uninfected MRC-5 cells were prepared simultaneously to serve as mock-infected controls for the cytokine/ chemokine profiles and migration assays. Varicella-zoster virus was inactivated at 65°C for 10 minutes (heat-inactivated VZV). Cells were infected at the indicated multiplicity of infection (MOI). Inocula were removed after 1 hour of absorption.
Immunoblotting
ARPE-19 and MRC-5 cells (2 × 10 5 ) were plated 24 hours before infection. Infected cells were harvested every 24 hours for 5 days. The harvested cells were washed once with phosphate-buffered saline (PBS) and centrifuged at 1500 rpm for 5 minutes at 4°C, resuspended in lysis buffer (50 mM HEPES pH 7.2, 250 mM NaCl, 2 mM EDTA, 0.1% NP-40, 1 mM DTT, 1 µg/mL aprotinin, 1 µg/mL leupeptin, 50 µg/mL PMSF, and 10 mM NaF), and kept on ice for 20 minutes. The lysates were clarified at 14 000 rpm for 10 minutes at 4°C. Total protein concentrations were determined using the DC protein assay (BioRad, Hercules, CA). Twenty micrograms of lysates were loaded on 12.5% SDS-PAGE gels. The separated proteins were transferred onto polyvinylidene difluoride membranes and probed for VZV ORF4 (mouse, 1:1000; Center for Proteomics, University of Rijeka, Croatia), VZV ORF47 (mouse, 1:4; Center for Proteomics), VZV glycoprotein E ([gE] mouse, 1:500; Santa Cruz Biotechnology, Santa Cruz, CA), and β-actin (mouse, 1: 10 000; Cell Signaling Technology), followed by appropriate horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology). The blots were visualized with the ChemiDoc XRS+ system (Bio-Rad). Experiments were repeated 3 times.
Immunofluorescence Microscopy
ARPE-19 and MRC-5 cells (2 × 10 5 ) were plated 24 hours before infection. Cells were infected as described above. Every 24 hours for 5 days, cells were fixed with 4% paraformaldehyde for 10 minutes, washed 3 times with PBS, and blocked with 5% goat serum in PBS containing 0.05% Tween for 1 hour at room temperature. Varicella-zoster virus IE62 (mouse, 1:250; Santa Cruz Biotechnology) or gE (mouse, 1:250) antibodies were incubated overnight at 4°C. Cells were detected with anti-mouse Alexa 488 (1:250). Nuclei were visualized with 4' ,6-diamidino-2-phenylindole at 1:500. At least 4 fields per treatment were imaged using a Nikon TS100 fluorescence microscope (Nikon Instruments, Melville, NY). Images were captured with a Nikon DS-Qi1 cooled camera head and analyzed with Nikon NIS-Elements software.
Plaque Assay to Measure Viral Titers
ARPE-19 and MRC-5 cells were plated at 2 × 10 5 cells/well 24 hours before infection. Cells were infected as described above. The infected cells were harvested at 1-5 days postinfection (dpi). The harvested cells were centrifuged at 1500 rpm for 5 minutes, resuspended in 10% DMEM supplemented with 10% dimethyl sulfoxide, and stored at −80°C. MRC-5 cells were plated at 5 × 10 4 cells/well 3 days prior or 1 × 10 5 cells/well 2 days before infection. Cells were infected in triplicate with the diluted samples (10 -1 to 10 -4 ) and cultured in 2% DMEM. After 7 days, the cells were fixed with methanol and stained with crystal violet solution (0.5% crystal violet in 25% methanol). The plaques were counted to calculate the PFU/mL of each sample.
Flow Cytometry
The percentage of gE expression on live cells was quantitated on a LSR II (BD Biosciences, San Jose, CA) at 1-5 days postinfection by staining with Zenon R-PE-labeled (Thermo Fisher, Waltham, MA) mouse anti-gE (EMD Millipore, Billerica, MA). Analysis was performed using FlowJo (Ashland, OR).
Cell Culture Supernatants
ARPE-19 or MeWo cells (1 × 10 5 ) were plated 24 hours before infection. Cells were infected as described above. Cell culture supernatants collected at 1, 4, and 8 days postinfection were clarified by centrifugation, snap frozen, and stored at −80°C for analysis in the multiplex and migration assays. Samples were thawed once.
Proinflammatory and Chemotactic Cytokine Profiles
Cell culture supernatants were analyzed with MesoScale V-PLEX , and the data were analyzed using the MSD Discovery Workbench software. Three to four biological sets of supernatants were analyzed.
T-Cell Isolations
Freshly isolated PBMCs were rested overnight at 37°C. The next day, CD4 + and CD8 + T cells were separated by negative selection using the MACS CD4 + and CD8 + T-cell Isolation Kits (Miltenyi Biotec, Auburn, CA), respectively, according to the manufacturer's protocol. The purity of T cells was determined to be >90% on an LSR II using anti-CD3-fluorescein isothiocyanate (FITC) and anti-CD4-PerCP-Cy5.5 and >80% using anti-CD3-FITC and anti-CD8-R-PE (BD Biosciences).
T-Cell Migration Assays
Chemotaxis was assayed by using Transwell inserts ([diameter, 6.5 mm; pore, 5 µm] Costar, Cambridge, MA) in 24-well culture plates. One hundred microliters of 10% Roswell Park Memorial Institute medium containing 5 × 10 5 CD4 + or CD8 + T cells were added to the upper chamber, and 0.6 mL of culture supernatant from ARPE-19 cells was added to the bottom chamber. After 3 hours at 37°C, the average number of CD4 + T cells that migrated to the lower chamber was enumerated from 4 randomly selected high-power fields for each sample. Because greater CD8 + T-cell migration was observed, a hemocytometer was used to enumerate the average number of CD8 + T cells. Three to four biological sets of supernatants were tested.
Statistical Analyses
Statistical significance of viral titers and T-cell migration was determined using paired t tests. For the cytokine profiles, 7 outliers were identified out of 612 data values for ARPE-19 cells (1.1% of the total) and 2 outliers were identified out of 459 data values for the MeWo cells (0.4% of the total), and excluded within each day by treatment group using Grubbs' test. Linear regression analysis of variance models including day, treatment, and treatment by day interactions assessed group differences. For each outcome, analysis first assessed potential interactions between day and treatment. If interaction was present, pairwise comparisons tests assessed differences between treatments within day. If there was no interaction, then the overall F test for a difference between treatment groups assessed any group difference. Bonferroni correction to control for multiple comparisons testing set the alpha level for significance at α = 0.0029 (17 cytokines) for initial treatment by time interaction tests and treatment tests. Tukey's adjustment controlled for multiple testing in subsequent pairwise comparisons at α = 0.05.
RESULTS
Infection of ARPE-19 Cells Results in Typical Kinetics of Varicella-Zoster Virus Protein Expression but Decreased Virus Production
First, we tested whether VZV infection of ARPE-19 cells follows the typical sequence of appearance of VZV proteins observed in MRC-5 fibroblasts. ARPE-19 and MRC-5 cells were infected with cell-associated ROka, and viral protein production was monitored over 5 days by immunoblotting and immunofluorescence microscopy. Immunoblotting showed that ORF4, an immediate-early (IE) VZV protein, was detected at 1-day postinfection (dpi) and increased during the 5-day period in both cell types ( Figure 1A ). ORF47 and gE, early and late VZV proteins, respectively, were detected at 2 dpi, and their expression increased over 5 days, similar to ORF4 ( Figure 1A ). The kinetics of IE62, another IE protein and the major transactivator, and gE were also monitored by fluorescence microscopy. IE62 expression was visible at 1 dpi, and spread until 3 dpi, but then became difficult to detect at 4 and 5 dpi in ARPE-19 cells ( Figure 1B) . In contrast, IE62 expression in MRC-5 cells was readily detected from 1 to 4 dpi ( Figure 1C) . In ARPE-19 and MRC-5 cells, gE was observed at 1 dpi and its expression progressively increased over the 5 days. We also quantitated the fraction of live cells that expressed gE by flow cytometry, and we found that at 2 different cell densities and MOIs, there was a lower percentage of ARPE-19 cells expressing gE compared with MRC-5 cells ( Figure 1D ). Finally, we measured the amount of infectious virus produced in the 2 cell types by plaque assay. Although ROka was able to replicate in ARPE-19 and MRC-5 cells, it did so significantly more efficiently in MRC-5 cells (Figure 2 ). Our findings demonstrate that although ARPE-19 cells support cell-associated VZV infection, they exhibit a shortened and reduced expression of IE62 and decreased replication when compared with infection of MRC-5 fibroblasts.
Proinflammatory and Chemotactic Cytokine Responses to VaricellaZoster Virus-Infected ARPE-19 and MeWo Cells
Using sensitive multiplex assays, we measured the proinflammatory and chemotactic cytokines secreted by ARPE-19 and MeWo cells after VZV infection (Figure 3) . MeWo cells, which are commonly used to model VZV infection of the skin, were included to provide a comparison to the findings in ARPE-19 cells. Heatinactivated VZV was included to determine whether infection and replication are required for the production of cytokines, or whether antigen alone is sufficient. In ARPE-19 cells, the production of cytokines increased over time with all treatment groups, which differed from the relatively stable expression of cytokines over time with all treatment groups in MeWo cells. Of the 3 treatments, mock infection of MeWo cells appeared to induce the highest amounts of almost all of the cytokines, and treatment with heat-inactivated or infectious VZV suppressed their production. This observation differed from the ARPE-19 cells, where several cytokines were induced by VZV infection. CXCL8/IL-8, CCL2/ MCP-1, and IL-6 were the most abundantly produced cytokines (nanogram to microgram range) in both cell types.
ARPE-19 Cells
CXCL8/IL-8, CCL26/eotaxin-3, and TNF-α expression was significantly greater in supernatants released from 
MRC-5
β-actin 5 dpi 4 dpi 3 dpi 2 dpi 1 dpi Uninfected 5 dpi 4 dpi 3 dpi 2 dpi 1 dpi VZV-infected cells at 8 dpi compared with supernatants induced by heat-inactivated VZV and mock infection at the same time. The induction of these cytokines required infectious VZV, because use of heat-inactivated VZV failed to do so. Many cytokines, such as CCL11/eotaxin, CCL2/MCP-1, CCL13/MCP-4, IL-1β, IL-4, IL-6, IL-12, and IFN-γ, were inhibited by infectious and heat-inactivated VZV, some at multiple times postinfection and others more apparent at 8 dpi. The remaining cytokines were produced in similar amounts by ARPE-19 cells despite the type of stimuli received. It should be noted that although the levels of a majority of cytokines over time was low (<10 pg/mL), their production was above the limit of detection.
MeWo Cells
The only cytokine induced by VZV infection was IL-10 at 8 dpi. Its production was also dependent on the use of infectious VZV. CCL4/MIP-1β was completely inhibited by treatment with heat-inactivated and infectious VZV.
Varicella-Zoster Virus-Infected ARPE-19 Supernatants Promote Different Kinetics and Magnitude of CD4 + and CD8 + T-Cell
Migration
Chemokines comprise a large family of cytokines that function in leukocyte trafficking under homeostatic as well as inflammatory conditions [27] [28] [29] . Previous studies demonstrated that T cells predominate in ocular fluids during uveitis [8, 9] . Thus, we evaluated the ability of the chemokines in the supernatants from the different treatments of ARPE-19 cells to attract T cells. We observed a greater number of migrating CD8 + T cells than CD4 + T cells (Figure 4) . A significant increase in CD8 + T cells occurred maximally at 1 dpi in response to chemokines in supernatants from infectious and heat-inactivated VZV-treated cells. By 8 dpi, there was no difference in CD8 + T-cell migration with the different stimuli used ( Figure 4A ). In contrast, an enhancement in CD4 + T-cell migration was apparent at 1 dpi, but it continued to increase and reach maximal numbers at 8 dpi ( Figure 4B ). The enhanced migration was not observed with heat-activated VZV treatment, suggesting that viral infection and/or replication, not antigen alone, was necessary to produce chemokines that stimulated CD4 + , but not CD8 + , T-cell migration.
DISCUSSION
Uveitis is one of the leading causes of blindness in the United States and the world. Varicella-zoster virus is responsible for the majority of ARN cases, a rare but clinically serious form of posterior uveitis, which can result in vision loss due to retinal detachment and chronic inflammation. Contemporary therapy includes specific antiviral drugs and corticosteroids because the immune response is considered to be an important component of the pathology of VZV-induced uveitis. This aspect of uveitis cannot be studied solely with clinical specimens because of the aforementioned limitations. Thus, we infected ARPE-19 cells, which are derived from primary RPE, with VZV to increase our understanding about the role of RPE in the immunologic response to VZV infection. We are aware of the controversies and limitations surrounding the use of ARPE-19 cells for ocular diseases [30] . However, there are no available methods to study the intact retina, and a study examining the cytokine responses in primary RPE versus ARPE-19 cells did not identify any differences between the 2 cell types [31] . Our data suggest that other cell types, both retinal as well as immunologic, are likely to contribute to the cytokine responses observed in vivo.
Previous reports demonstrated that ARPE-19 cells support cell-free VZV infection [32] [33] [34] [35] . We established that ARPE-19 cells can also be infected with cell-associated VZV; however, the lower viral titers we observed are most likely due to the cell-associated nature of our infections, whereas previous reports using cell-free VZV generated higher viral titers [34] . When compared with MRC-5 cells, our data indicated that IE62 expression decreased and declined earlier in ARPE-19 cells, with fewer cells expressing IE62 after 3 dpi. Because IE62 serves as the major transactivator protein necessary for the sequential expression of later VZV proteins, reduction in its expression would limit viral propagation and likely explains the lower viral titers we observed in ARPE-19 cells. In addition, the decrease in percentage of gE expression observed in ARPE-19 cells may also contribute to the lower viral titers in these cells.
Our study is the first to characterize an extensive cytokine profile of ARPE-19 and MeWo cells in response to VZV infection in vitro. We included heat-inactivated VZV as a control (as opposed to UV-inactivated virus) because heat-inactivated virus does not have the ability to infect cells [36] [37] [38] . By comparing treatment of ARPE-19 and MeWo cells with infectious versus heat-inactivated VZV, we determined that viral replication was necessary for the stimulation of several cytokines. Furthermore, because cell-associated infectious and heat-inactivated VZV were used in our studies, Time ( we included a mock condition in which the same MRC-5 cells used to make cell-associated VZV was applied to ARPE-19 and MeWo cells; thus, it was not surprising that certain cytokines are made in response to this stimulus. What was surprising was that the cytokine responses to mock-infected MeWo cells stimulated peak levels of the majority of cytokines, which remained stable over time. This profile differed from the ARPE-19 cells, which generally expressed lower levels of cytokines that increased with time. Altogether, our data suggests that cytokine responses in ARPE-19 cells are unique and distinct from MeWo cells. In particular, we found that VZVinfected ARPE-19 cells secreted high levels of CCL2/MCP-1, CXCL8/IL-8, IL-6, and IL-10 and low levels of IL-2, IL-4, IL-13, and TNF-α, which are in agreement with several cytokine profiles of ocular fluid from herpesviral uveitis patients [13, 14, [16] [17] [18] [19] 39] .
A limitation of such studies, acknowledged by the authors of these reports, is that it cannot be deduced which cell type(s) are responsible for the production of these mediators. Our work suggests that CCL2/MCP-1, CXCL8/IL-8, IL-6, and IL-10 may be produced by infected RPE in vivo. Interferon-γ was also abundantly produced in ocular fluid in some herpesviral uveitis studies [13, 15, 17, 39] , but it was detected at low levels in our studies, suggesting that other ocular and/or immune cells likely contribute to IFN-γ production in vivo. It is interesting to note that our collective results closely resemble the recent findings of cytokines and chemokines in the ocular fluid of ARN patients [18] , where IL-6, CXCL8/IL-8, and CCL2/MCP-1 were elevated but IFN-γ was not. The expression of a number of cytokines (CCL2/MCP-1, CCL11/eotaxin, CCL13/MCP-4, IL-1β, IL-4, IL-12, IFN-γ) was inhibited by both infectious and heat-inactivated VZV, indicating that the presence of viral antigen alone either inhibited their production or the cytokines were competitively bound. Herpes simplex virus type 1 has been shown to inhibit the expression of proinflammatory cytokines by mediating messenger ribonucleic acid stability [40] . Poxviruses, as well as several members of herpesvirus subfamilies, encode viral chemokines or chemokine receptors that mimic host proteins [41] [42] [43] , thereby competitively binding these molecules and preventing detection by the immune system. Infectious VZV was required for the production of several of the highly elevated cytokines (CCL2/IL-8, CCL26/eotaxin-3, IL-6, IL-10), suggesting that their induction is dependent on the process of infection and/or replication.
We also examined the ability of the net effect of the cytokines produced by VZV-infected ARPE-19 cells to induce T-cell migration. The magnitude of CD8 + T-cell migration (1) was greater than CD4 + T cells, (2) peaked earlier, and (3) decreased over time. This is consistent with a model that CD8 + T cells function to quickly limit disease severity and delay disease progression [44, 45] . There was a characteristic delay in the CD4 + T-cell response to cytokines from infected ARPE-19 cells, but the CD4 + T-cell response did not decline with time. This could be a direct consequence of the persistent expression of chemotactic cytokines produced by ARPE-19 cells, which may contribute to and explain the inflammation associated with VZV-induced uveitis by providing sustained signals for T-cell recruitment. For example, high levels of CCL2/MCP-1, CCL3/ MIP-1α, and CCL4/MIP-β observed during autoimmune uveitis contribute to the recruitment of inflammatory cells and disease progression [46] . During hepatitis B infection, high CXCL10/ IP-10 and CXCL9/Mig levels correlate with more severe liver disease, and their neutralization is associated with maintenance of antiviral effects but diminished tissue damage [47] . We also determined that CD8 + T cells migrated towards cytokines produced by infectious and heat-inactivated VZV, whereas CD4 + T cells migrated towards cytokines produced specifically by infectious VZV.
CONCLUSIONS
In summary, our findings indicate that VZV infection of ARPE-19 cells provides additional information about the immunologic responses in VZV-associated posterior uveitis patients, suggesting that it can serve as a useful platform for future studies to address mechanisms underlying the immunopathology of this disease.
Notes
